Anti-Staphylococcus Aureus Effects of Natural Antimicrobial Peptides and the Underlying Mechanisms

References

• Balasubramanian D, Harper L, Shopsin B, Torres VJ. Staphylococcus aureus pathogenesis in diverse host environments. Pathog Dis 75(1), doi: 10.1093/femspd/ftx005 (2017).
   PubMed Web of Science ®Google Scholar
• Tam K, Torres VJ. Staphylococcus aureus secreted toxins and extracellular enzymes. Microbiol. Spectr. 7(2), doi: 10.1128/microbiolspec.GPP3-0039-2018 (2019).
   PubMed Web of Science ®Google Scholar
• Oliveira D, Borges A, Simões M. Staphylococcus aureus toxins and their molecular activity in infectious diseases. Toxins 10(6), doi: 10.3390/toxins10060252 (2018).
   Web of Science ®Google Scholar
• Kwiecinski JM, Horswill AR. Staphylococcus aureus bloodstream infections: pathogenesis and regulatory mechanisms. Curr. Opin. Microbiol. 53, 51–60 (2020).
   PubMed Web of Science ®Google Scholar
• Ahmad-Mansour N, Loubet P, Pouget C et al. Staphylococcus aureus toxins: an update on their pathogenic properties and potential treatments. Toxins 13(10), doi: 10.3390/toxins13100677 (2021).
   PubMed Web of Science ®Google Scholar
• Álvarez A, Fernández L, Gutiérrez D, Iglesias B, Rodríguez A, García P. Methicillin-resistant Staphylococcus aureus in hospitals: latest trends and treatments based on bacteriophages. J. Clin. Microbiol. 57(12), doi: 10.1128/JCM.01006-19 (2019).
   PubMed Web of Science ®Google Scholar
• Cascioferro S, Carbone D, Parrino B et al. Therapeutic strategies to counteract antibiotic resistance in MRSA biofilm-associated infections. ChemMedChem 16(1), 65–80 (2021).
   PubMed Web of Science ®Google Scholar
• Lee AS, De Lencastre H, Garau J et al. Methicillin-resistant Staphylococcus aureus . Nat. Rev. Dis. Primers 4, 18033 (2018).
   PubMed Web of Science ®Google Scholar
• Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 284(5418), 1318–1322 (1999).
   PubMed Web of Science ®Google Scholar
• Høiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O. Antibiotic resistance of bacterial biofilms. Int. J. Antimicrob. Agents 35(4), 322–332 (2010).
   PubMed Web of Science ®Google Scholar
• Hall CW, Mah TF. Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria. FEMS Microbiol. Rev. 41(3), 276–301 (2017).
   PubMed Web of Science ®Google Scholar
• Wiesner J, Vilcinskas A. Antimicrobial peptides: the ancient arm of the human immune system. Virulence 1(5), 440–464 (2010).
   PubMed Web of Science ®Google Scholar
• Park S, Park SH, Ahn HC et al. Structural study of novel antimicrobial peptides, nigrocins, isolated from Rana nigromaculata . FEBS Lett. 507(1), 95–100 (2001).
   PubMed Web of Science ®Google Scholar
• Fitton JE, Dell A, Shaw WV. The amino acid sequence of the delta haemolysin of Staphylococcus aureus . FEBS Lett. 115(2), 209–212 (1980).
   PubMed Web of Science ®Google Scholar
• Boman HG, Hultmark D. Cell-free immunity in insects. Annu. Rev. Microbiol. 41, 103–126 (1987).
   PubMed Web of Science ®Google Scholar
• Jenssen H, Hamill P, Hancock RE. Peptide antimicrobial agents. Clin. Microbiol. Rev. 19(3), 491–511 (2006).
   PubMed Web of Science ®Google Scholar
• Rončević T, Puizina J, Tossi A. Antimicrobial peptides as anti-infective agents in pre-post-antibiotic era? Int. J. Mol. Sci. 20(22), doi: 10.3390/ijms20225713 (2019).
   PubMed Web of Science ®Google Scholar
• Luo Y, Song Y. Mechanism of antimicrobial peptides: antimicrobial, anti-inflammatory and antibiofilm activities. Int. J. Mol. Sci. 22(21), doi: 10.3390/ijms222111401 (2021).
   Web of Science ®Google Scholar
• Hemmati F, Rezaee MA, Ebrahimzadeh S et al. Novel strategies to combat bacterial biofilms. Mol. Biotechnol. 63(7), 569–586 (2021).
   PubMed Web of Science ®Google Scholar
• Shahrour H, Ferrer-Espada R, Dandache I et al. AMPs as anti-biofilm agents for human therapy and prophylaxis. Adv. Exp. Med. Biol. 1117, 257–279 (2019).
   PubMed Web of Science ®Google Scholar
• Moravej H, Moravej Z, Yazdanparast M et al. Antimicrobial peptides: features, action, and their resistance mechanisms in bacteria. Microb. Drug Resist. 24(6), 747–767 (2018).
   PubMed Web of Science ®Google Scholar
• Sierra JM, Fusté E, Rabanal F, Vinuesa T, Viñas M. An overview of antimicrobial peptides and the latest advances in their development. Expert Opin. Biol. Ther. 17(6), 663–676 (2017).
   PubMed Web of Science ®Google Scholar
• Volejníková A, Melicherčík P, Nešuta O et al. Antimicrobial peptides prevent bacterial biofilm formation on the surface of polymethylmethacrylate bone cement. J. Med. Microbiol. 68(6), 961–972 (2019).
   PubMed Web of Science ®Google Scholar
• Segev-Zarko L, Saar-Dover R, Brumfeld V, Mangoni ML, Shai Y. Mechanisms of biofilm inhibition and degradation by antimicrobial peptides. Biochem. J. 468(2), 259–270 (2015).
   PubMedGoogle Scholar
• Yasir M, Willcox MDP, Dutta D. Action of antimicrobial peptides against bacterial biofilms. Materials 11(12), doi: 10.3390/ma11122468 (2018).
   PubMed Web of Science ®Google Scholar
• Lipsky BA, Holroyd KJ, Zasloff M. Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded, multicenter trial of pexiganan cream. Clin. Infect. Dis. 47(12), 1537–1545 (2008).
   PubMed Web of Science ®Google Scholar
• Méndez-Samperio P. Peptidomimetics as a new generation of antimicrobial agents: current progress. Infect. Drug Resist. 7, 229–237 (2014).
   PubMed Web of Science ®Google Scholar
• Nilsson AC, Janson H, Wold H et al. LTX-109 is a novel agent for nasal decolonization of methicillin-resistant and -sensitive Staphylococcus aureus . Antimicrob. Agents Chemother. 59(1), 145–151 (2015).
   PubMed Web of Science ®Google Scholar
• Haisma EM, De Breij A, Chan H et al. LL-37-derived peptides eradicate multidrug-resistant Staphylococcus aureus from thermally wounded human skin equivalents. Antimicrob. Agents Chemother. 58(8), 4411–4419 (2014).
   PubMed Web of Science ®Google Scholar
• Rajasekaran G, Kim EY, Shin SY. LL-37-derived membrane-active FK-13 analogs possessing cell selectivity, anti-biofilm activity and synergy with chloramphenicol and anti-inflammatory activity. Biochim. Biophys. Acta Biomembr. 1859(5), 722–733 (2017).
   PubMed Web of Science ®Google Scholar
• Narayana JL, Mishra B, Lushnikova T, Golla RM, Wang G. Modulation of antimicrobial potency of human cathelicidin peptides against the ESKAPE pathogens and in vivo efficacy in a murine catheter-associated biofilm model. Biochim. Biophys. Acta Biomembr. 1861(9), 1592–1602 (2019).
   PubMed Web of Science ®Google Scholar
• De Breij A, Riool M, Cordfunke RA et al. The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms. Sci. Transl. Med. 10(423), doi: 10.1126/scitranslmed.aan4044 (2018).
   Web of Science ®Google Scholar
• Huang Q, Yu HJ, Liu GD et al. Comparison of the effects of human β-defensin 3, vancomycin, and clindamycin on Staphylococcus aureus biofilm formation. Orthopedics 35(1), e53–60 (2012).
   PubMed Web of Science ®Google Scholar
• Zhu C, Tan H, Cheng T et al. Human β-defensin 3 inhibits antibiotic-resistant Staphylococcus biofilm formation. J. Surg. Res. 183(1), 204–213 (2013).
   PubMed Web of Science ®Google Scholar
• Feldman M, Smoum R, Mechoulam R, Steinberg D. Antimicrobial potential of endocannabinoid and endocannabinoid-like compounds against methicillin-resistant Staphylococcus aureus . Sci. Rep. 8(1), 17696 (2018).
   PubMedGoogle Scholar
• Zhou W, Du Y, Li X, Yao C. Lipoic acid modified antimicrobial peptide with enhanced antimicrobial properties. Bioorgan. Med. Chem. 28(19), 115682 (2020).
   PubMed Web of Science ®Google Scholar
• Jiale Z, Jian J, Xinyi T, Haoji X, Xueqin H, Xiao W. Design of a novel antimicrobial peptide 1018M targeted ppGpp to inhibit MRSA biofilm formation. AMB Express 11(1), 49 (2021).
   PubMed Web of Science ®Google Scholar
• Wu X, Pan J, Wu Y et al. PSN-PC: a novel antimicrobial and anti-biofilm peptide from the skin secretion of Phyllomedusa-camba with cytotoxicity on human lung cancer cell. Molecules 22(11), doi: 10.3390/molecules22111896 (2017).
   Web of Science ®Google Scholar
• Yuan Y, Zai Y, Xi X et al. A novel membrane-disruptive antimicrobial peptide from frog skin secretion against cystic fibrosis isolates and evaluation of anti-MRSA effect using Galleria mellonella model. Biochim. Biophys. Acta Gen. Subj. 1863(5), 849–856 (2019).
   PubMed Web of Science ®Google Scholar
• Liu J, Wu Q, Li L et al. Discovery of phylloseptins that defense against Gram-positive bacteria and inhibit the proliferation of the non-small cell lung cancer cell line, from the skin secretions of Phyllomedusa frogs. Molecules 22(9), doi: 10.3390/molecules22091428 (2017).
   Web of Science ®Google Scholar
• Song X, Pan H, Wang H et al. Identification of new dermaseptins with self-assembly tendency: membrane disruption, biofilm eradication, and infected wound healing efficacy. Acta Biomater. 109, 208–219 (2020).
   PubMed Web of Science ®Google Scholar
• Golda A, Kosikowska-Adamus P, Kret A et al. The bactericidal activity of temporin analogues against methicillin resistant Staphylococcus aureus . Int. J. Mol. Sci 20(19), doi: 10.3390/ijms20194761 (2019).
   PubMed Web of Science ®Google Scholar
• Yang N, Teng D, Mao R et al. A recombinant fungal defensin-like peptide-P2 combats multidrug-resistant Staphylococcus aureus and biofilms. Appl. Microbiol. Biotechnol. 103(13), 5193–5213 (2019).
   PubMed Web of Science ®Google Scholar
• Vasilchenko AS, Julian WT, Lapchinskaya OA, Katrukha GS, Sadykova VS, Rogozhin EA. A novel peptide antibiotic produced by Streptomyces roseoflavus strain INA-Ac-5812 with directed activity against Gram-positive bacteria. Front. Microbiol. 11, 556063 (2020).
   PubMed Web of Science ®Google Scholar
• Ma Z, Han J, Chang B et al. Membrane-active amphipathic peptide WRL3 with in vitro antibiofilm capability and in vivo efficacy in treating methicillin-resistant Staphylococcus aureus burn wound infections. ACS Infect. Dis. 3(11), 820–832 (2017).
   PubMed Web of Science ®Google Scholar
• Sandiford S, Upton M. Identification, characterization, and recombinant expression of epidermicin NI01, a novel unmodified bacteriocin produced by Staphylococcus epidermidis that displays potent activity against Staphylococci . Antimicrob. Agents Chemother. 56(3), 1539–1547 (2012).
   PubMed Web of Science ®Google Scholar
• Saising J, Dube L, Ziebandt AK, Voravuthikunchai SP, Nega M, Götz F. Activity of gallidermin on Staphylococcus aureus and Staphylococcus epidermidis biofilms. Antimicrob. Agents Chemother. 56(11), 5804–5810 (2012).
   PubMed Web of Science ®Google Scholar
• Shi J, Chen C, Wang D, Tong Z, Wang Z, Liu Y. Amphipathic peptide antibiotics with potent activity against multidrug-resistant pathogens. Pharmaceutics 13(4), doi: 10.3390/pharmaceutics13040438 (2021).
   Web of Science ®Google Scholar
• Okuda K, Zendo T, Sugimoto S et al. Effects of bacteriocins on methicillin-resistant Staphylococcus aureus biofilm. Antimicrob. Agents Chemother. 57(11), 5572–5579 (2013).
   PubMed Web of Science ®Google Scholar
• Wei G, He Y. Antibacterial and antibiofilm activities of novel cyclic peptides against methicillin-resistant Staphylococcus aureus . Int. J. Mol. Sci. 23(14), doi: 10.3390/ijms23148029 (2022).
   Web of Science ®Google Scholar
• Xiong F, Dai X, Li YX et al. Effects of the antimicrobial peptide L12 against multidrug-resistant Staphylococcus aureus . Mol. Med. Rep. 19(4), 3337–3344 (2019).
   PubMed Web of Science ®Google Scholar
• Han J, Ma Z, Gao P et al. The antibacterial activity of LI-F type peptide against methicillin-resistant Staphylococcus aureus (MRSA) in vitro and inhibition of infections in murine scalded epidermis. Appl. Microbiol. Biotechnol. 102(5), 2301–2311 (2018).
   PubMed Web of Science ®Google Scholar
• Oyama LB, Olleik H, Teixeira ACN et al. In silico identification of two peptides with antibacterial activity against multidrug-resistant Staphylococcus aureus . NPJ Biofilms Microbiomes 8(1), 58 (2022).
   PubMed Web of Science ®Google Scholar
• Mataraci E, Dosler S. In vitro activities of antibiotics and antimicrobial cationic peptides alone and in combination against methicillin-resistant Staphylococcus aureus biofilms. Antimicrob. Agents Chemother. 56(12), 6366–6371 (2012).
   PubMed Web of Science ®Google Scholar
• Santana FL, Estrada K, Alford MA et al. Novel alligator cathelicidin As-CATH8 demonstrates anti-infective activity against clinically relevant and crocodylian bacterial pathogens. Antibiotics 11(11), doi: 10.3390/antibiotics11111603 (2022).
   Google Scholar
• Mishra B, Wang X, Lushnikova T et al. Antibacterial, antifungal, anticancer activities and structural bioinformatics analysis of six naturally occurring temporins. Peptides 106, 9–20 (2018).
   PubMed Web of Science ®Google Scholar
• Rocha LQ, Orzaéz M, García-Jareño AB et al. Dinoponera quadriceps venom as a source of active agents against Staphylococcus aureus . Toxicon 189, 33–38 (2021).
   PubMed Web of Science ®Google Scholar
• Choi JH, Jang AY, Lin S et al. Melittin, a honeybee venom-derived antimicrobial peptide, may target methicillin-resistant Staphylococcus aureus . Mol. Med. Rep. 12(5), 6483–6490 (2015).
   PubMed Web of Science ®Google Scholar
• Lima WG, de Brito JCM, Cardoso VN, Fernandes SOA. In-depth characterization of antibacterial activity of melittin against Staphylococcus aureus and use in a model of non-surgical MRSA-infected skin wounds. Eur. J. Pharm. Sci. 156, 105592 (2021).
   PubMed Web of Science ®Google Scholar
• Memariani H, Memariani M, Pourmand MR. Venom-derived peptide mastoparan-1 eradicates planktonic and biofilm-embedded methicillin-resistant Staphylococcus aureus isolates. Microb. Pathog. 119, 72–80 (2018).
   PubMed Web of Science ®Google Scholar
• Wang B, Yao Y, Wei P et al. Housefly phormicin inhibits Staphylococcus aureus and MRSA by disrupting biofilm formation and altering gene expression in vitro and in vivo . J. Biol. Macromol. 167, 1424–1434 (2021).
   PubMed Web of Science ®Google Scholar
• Oh JH, Park J, Park Y. Anti-biofilm and anti-inflammatory effects of lycosin-II isolated from spiders against multi-drug resistant bacteria. Biochim. Biophys. Acta Biomembr. 1864(1), 183769 (2022).
   PubMed Web of Science ®Google Scholar
• Li Z, Xu X, Meng L et al. Hp1404, a new antimicrobial peptide from the scorpion Heterometrus petersii . PLOS ONE 9(5), e97539 (2014).
   PubMed Web of Science ®Google Scholar
• Wang X, Hong X, Chen F, Wang KJ. A truncated peptide Spgillcin (177–189) derived from mud crab Scylla paramamosain exerting multiple antibacterial activities. Front. Cell. Infect. Microbiol. 12, 928220 (2022).
   PubMed Web of Science ®Google Scholar
• Farha MA, El-Halfawy OM, Gale RT et al. Uncovering the hidden antibiotic potential of cannabis. ACS Infect. Dis. 6(3), 338–346 (2020).
   PubMed Web of Science ®Google Scholar
• Overhage J, Campisano A, Bains M, Torfs EC, Rehm BH, Hancock RE. Human host defense peptide LL-37 prevents bacterial biofilm formation. Infect. Immun. 76(9), 4176–4182 (2008).
   PubMed Web of Science ®Google Scholar
• Harder J, Bartels J, Christophers E, Schroder JM. Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J. Biol. Chem. 276(8), 5707–5713 (2001).
   PubMed Web of Science ®Google Scholar
• Milman G, Maor Y, Abu-Lafi S et al. N-arachidonoyl L-serine, an endocannabinoid-like brain constituent with vasodilatory properties. Proc. Natl Acad. Sci. USA 103(7), 2428–2433 (2006).
   PubMed Web of Science ®Google Scholar
• Spindler EC, Hale JD, Giddings TH Jr , Hancock RE, Gill RT. Deciphering the mode of action of the synthetic antimicrobial peptide Bac8c. Antimicrob. Agents Chemother. 55(4), 1706–1716 (2011).
   PubMed Web of Science ®Google Scholar
• Lee H, Lee DG. SOS genes contribute to Bac8c induced apoptosis-like death in Escherichia coli . Biochimie 157, 195–203 (2019).
   PubMed Web of Science ®Google Scholar
• Spindler EC, Boyle NR, Hancock RE, Gill RT. Genome-wide identification of genes conferring energy related resistance to a synthetic antimicrobial peptide (Bac8c). PLOS ONE 8(1), e55052 (2013).
   PubMed Web of Science ®Google Scholar
• Mansour SC, de la Fuente-Núñez C, Hancock RE. Peptide IDR-1018: modulating the immune system and targeting bacterial biofilms to treat antibiotic-resistant bacterial infections. J. Pept. Sci. 21(5), 323–329 (2015).
   PubMed Web of Science ®Google Scholar
• He X, Yang S, Wei L, Liu R, Lai R, Rong M. Antimicrobial peptide diversity in the skin of the torrent frog, Amolops jingdongensis . Amino Acids 44(2), 481–487 (2013).
   PubMed Web of Science ®Google Scholar
• Feng G, Wu J, Yang HL, Mu L. Discovery of antioxidant peptides from amphibians: a review. Protein Pept. Lett. 28(11), 1220–1229 (2021).
   PubMed Web of Science ®Google Scholar
• Bergaoui I, Zairi A, Tangy F, Aouni M, Selmi B, Hani K. In vitro antiviral activity of dermaseptin S(4) and derivatives from amphibian skin against herpes simplex virus type 2. J. Med. Virol. 85(2), 272–281 (2013).
   PubMed Web of Science ®Google Scholar
• Van Zoggel H, Hamma-Kourbali Y, Galanth C et al. Antitumor and angiostatic peptides from frog skin secretions. Amino Acids 42(1), 385–395 (2012).
   PubMed Web of Science ®Google Scholar
• Chen X, Liu S, Fang J et al. Peptides isolated from amphibian skin secretions with emphasis on antimicrobial peptides. Toxins 14(10), doi: 10.3390/toxins14100722 (2022).
   Web of Science ®Google Scholar
• Mangoni ML, Grazia AD, Cappiello F, Casciaro B, Luca V. Naturally occurring peptides from Rana temporaria: antimicrobial properties and more. Curr. Top. Med. Chem. 16(1), 54–64 (2016).
   PubMed Web of Science ®Google Scholar
• Kemung HM, Tan LT, Khan TM et al. Streptomyces as a prominent resource of future anti-MRSA drugs. Front. Microbiol. 9, 2221 (2018).
   PubMed Web of Science ®Google Scholar
• Sun P, Maloney KN, Nam SJ et al. Fijimycins A–C, three antibacterial etamycin-class depsipeptides from a marine-derived Streptomyces sp. Bioorgan. Med. Chem. 19(22), 6557–6562 (2011).
   PubMed Web of Science ®Google Scholar
• Lapchinskaya OA, Katrukha GS, Gladkikh EG et al. Investigation of the complex antibiotic INA-5812. Russ. J. Bioorganic Chem. 42(6), 664–671 (2016).
   Web of Science ®Google Scholar
• Ma Z, Yang J, Han J et al. Insights into the antimicrobial activity and cytotoxicity of engineered α-helical peptide amphiphiles. J. Med. Chem. 59(24), 10946–10962 (2016).
   PubMed Web of Science ®Google Scholar
• Kellner R, Jung G, Hörner T et al. Gallidermin: a new lanthionine-containing polypeptide antibiotic. Eur. J. Med. Chem. 177(1), 53–59 (1988).
   Google Scholar
• Götz F, Perconti S, Popella P, Werner R, Schlag M. Epidermin and gallidermin: staphylococcal antibiotics. Int. J. Med. Microbiol. 304(1), 63–71 (2014).
   PubMed Web of Science ®Google Scholar
• Lakshmaiah Narayana J, Mishra B, Lushnikova T et al. Two distinct amphipathic peptide antibiotics with systemic efficacy. Proc. Natl Acad. Sci. USA 117(32), 19446–19454 (2020).
   PubMed Web of Science ®Google Scholar
• Rogers LA. The inhibiting effect of Streptococcus lactis on Lactobacillus bulgaricus . J. Bacteriol. 16(5), 321–325 (1928).
   PubMedGoogle Scholar
• Fujita K, Ichimasa S, Zendo T et al. Structural analysis and characterization of lacticin Q, a novel bacteriocin belonging to a new family of unmodified bacteriocins of Gram-positive bacteria. Appl. Environ. Microbiol. 73(9), 2871–2877 (2007).
   PubMed Web of Science ®Google Scholar
• Sashihara T, Kimura H, Higuchi T et al. A novel lantibiotic, nukacin ISK-1, of Staphylococcus warneri ISK-1: cloning of the structural gene and identification of the structure. Biosci. Biotechnol. Biochem. 64(11), 2420–2428 (2000).
   PubMed Web of Science ®Google Scholar
• Zipperer A, Konnerth MC, Laux C et al. Human commensals producing a novel antibiotic impair pathogen colonization. Nature 535(7613), 511–516 (2016).
   PubMed Web of Science ®Google Scholar
• Bionda N, Pitteloud JP, Cudic P. Cyclic lipodepsipeptides: a new class of antibacterial agents in the battle against resistant bacteria. Future Med. Chem. 5(11), 1311–1330 (2013).
   PubMed Web of Science ®Google Scholar
• Deng Y, Lu Z, Bi H, Lu F, Zhang C, Bie X. Isolation and characterization of peptide antibiotics LI-F04 and polymyxin B6 produced by Paenibacillus polymyxa strain JSa-9. Peptides 32(9), 1917–1923 (2011).
   PubMed Web of Science ®Google Scholar
• De Mandal S, Panda AK, Murugan C, Xu X, Senthil Kumar N, Jin F. Antimicrobial peptides: novel source and biological function with a special focus on entomopathogenic nematode/bacterium symbiotic complex. Front. Microbiol. 12, 555022 (2021).
   PubMed Web of Science ®Google Scholar
• Mulpuru V, Semwal R, Varadwaj P, Mishra N. HAMP: a knowledge-base of antimicrobial peptides from human microbiome. Curr. Bioinform. (2020). https://doi.org/10.2174/1574893615999200802041228
   PubMed Web of Science ®Google Scholar
• Ma Y, Guo Z, Xia B et al. Identification of antimicrobial peptides from the human gut microbiome using deep learning. Nature Biotechnol. 40(6), 921–931 (2022).
   PubMed Web of Science ®Google Scholar
• Chalasani AG, Roy U, Nema S. Purification and characterisation of a novel antistaphylococcal peptide (ASP-1) from Bacillus sp. URID 12.1. Int. J. Antimicrob. Agents 51(1), 89–97 (2018).
   PubMed Web of Science ®Google Scholar
• Chalasani AG, Dhanarajan G, Nema S, Sen R, Roy U. An antimicrobial metabolite from Bacillus sp.: significant activity against pathogenic bacteria including multidrug-resistant clinical strains. Front. Microbiol. 6, 1335 (2015).
   PubMed Web of Science ®Google Scholar
• Santana FL, Arenas I, Haney EF, Estrada K, Hancock REW, Corzo G. Identification of a crocodylian β-defensin variant from Alligator mississippiensis with antimicrobial and antibiofilm activity. Peptides 141, 170549 (2021).
   PubMed Web of Science ®Google Scholar
• Merchant ME, Mills K, Leger N, Jerkins E, Vliet KA, McDaniel N. Comparisons of innate immune activity of all known living crocodylian species. Comp. Biochem. Physiol. B, Biochem. Mol. Biol. 143(2), 133–137 (2006).
   PubMed Web of Science ®Google Scholar
• Lima DB, Torres AF, Mello CP et al. Antimicrobial effect of Dinoponera quadriceps (Hymenoptera: formicidae) venom against Staphylococcus aureus strains. J. Appl. Microbiol 117(2), 390–396 (2014).
   PubMed Web of Science ®Google Scholar
• Rady I, Siddiqui IA, Rady M, Mukhtar H. Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy. Cancer Lett. 402, 16–31 (2017).
   PubMed Web of Science ®Google Scholar
• Lyu C, Fang F, Li B. Anti-tumor effects of melittin and its potential applications in clinic. Curr. Protein Pept. Sci. 20(3), 240–250 (2019).
   PubMed Web of Science ®Google Scholar
• Maiden MM, Zachos MP, Waters CM. Hydrogels embedded with melittin and tobramycin are effective against Pseudomonas aeruginosa biofilms in an animal wound model. Front. Microbiol. 10, 1348 (2019).
   PubMed Web of Science ®Google Scholar
• Picoli T, Peter CM, Zani JL et al. Melittin and its potential in the destruction and inhibition of the biofilm formation by Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa isolated from bovine milk. Microb. Pathog. 112, 57–62 (2017).
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang L, Yang H et al. The spider venom peptide lycosin-II has potent antimicrobial activity against clinically isolated bacteria. Toxins 8(5), doi: 10.3390/toxins8050119 (2016).
   Web of Science ®Google Scholar